Fluidx Completes Follow-Up in Multicenter Study of GPX Liquid Embolic Agent

October 2022

Fluidx Completes Enrollment in Trial for GPX Embolic Device

September 2022

New embolic device demonstrates superior vessel filling in tumour models

August 2022

Metastatic Tumor Treatment With Novel GPX Embolic Device

March 2022